The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.
about
The RIVUR trial: a factual interpretation of our dataAntimicrobial prophylaxis for children with vesicoureteral reflux.Estimating utility values for vesicoureteral reflux in the general public using an online tool.Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) TrialAntimicrobial Resistance and Urinary Tract Infection Recurrence.Estimation of the relationship between the polymorphisms of selected genes: ACE, AGTR1, TGFβ1 and GNB3 with the occurrence of primary vesicoureteral reflux.Relevance of current guidelines in the management of VUR.Long-term, low-dose prophylaxis against urinary tract infections in young children.Ultrasonography and C-reactive protein can predict the outcomes of voiding cystography after the first urinary tract infection.The Utility of Real-Time Quantitative Polymerase Chain Reaction Genotype Detection in the Diagnosis of Urinary Tract Infections in Children.Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography.Polymorphisms in α-Defensin-Encoding DEFA1A3 Associate with Urinary Tract Infection Risk in Children with Vesicoureteral Reflux.Primary vesicoureteral reflux: A 26-year experience in a single centre.Interobserver variability for interpretation of DMSA scans in the RIVUR trial.Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?Obese children at higher risk for having overactive bladder symptoms: a community-based study.Diagnostic accuracy of urine heparin binding protein for pediatric acute pyelonephritis
P2860
Q30882767-8744F1D3-E2FC-4A5B-9BBD-7260F09FDE67Q34063476-1841D6DF-6DB0-4B94-BB26-2B3886E39F40Q34289487-DED151DD-5CE4-4634-9AFF-3FEF74E40248Q36432920-78B416FB-590C-40F3-BBDC-B3F5A166C2A2Q36738347-6B1E4F13-0879-454A-A785-1E756C06134FQ37660514-B313C8A8-77EA-40CB-841F-F926CF449D25Q38175300-921EC1DD-4140-447F-9D51-A04B5E415758Q38218324-BBF87115-9905-4854-BDFD-924EA901D5B1Q40172525-D7AB54C0-E2BA-4CFE-8FE1-7A61A0CED6B1Q40240476-6CD94138-E4F9-4393-983B-755A3CEE5755Q40528270-8D7B30E2-E143-4D51-B2D1-66350C1B5AF0Q40768537-0B862213-2725-4E7B-80F6-BC013F95B8F1Q41000065-5205EE9E-151D-46F2-A854-D4C86B966F07Q47321449-232D83FA-BDCA-477F-8F0F-3FB52C29E0F3Q48101168-C45F8B35-F160-4A61-9ABA-D63D894348F5Q48141768-B939CB08-7920-4EFB-83AA-F300A43310F4Q57002223-FFB15C1B-6A42-4E16-A018-9EFAC11C9A3F
P2860
The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The RIVUR trial: profile and b ...... en with vesicoureteral reflux.
@en
type
label
The RIVUR trial: profile and b ...... en with vesicoureteral reflux.
@en
prefLabel
The RIVUR trial: profile and b ...... en with vesicoureteral reflux.
@en
P2093
P2860
P356
P1433
P1476
The RIVUR trial: profile and b ...... ren with vesicoureteral reflux
@en
P2093
Alejandro Hoberman
Myra A Carpenter
RIVUR Trial Investigators
Ranjiv Mathews
Russell W Chesney
Saul P Greenfield
Tej K Mattoo
P2860
P304
P356
10.1542/PEDS.2012-2301
P407
P577
2013-06-10T00:00:00Z